Loading…
Lasmiditan is an effective acute treatment for migraine: A phase 3 randomized study
Kuca, Bernice, Silberstein, Stephen D, Wietecha, Linda, Berg, Paul H, Dozier, Gregory, Lipton, Richard B
Published in Neurology (11.12.2018)
Published in Neurology (11.12.2018)
Get more information
Journal Article
Loading…
Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan – A randomised proof-of-concept trial
Ferrari, Michel D, Färkkilä, Markus, Reuter, Uwe, Pilgrim, Alison, Davis, Charles, Krauss, Martin, Diener, Hans-Christoph
Published in Cephalalgia (01.10.2010)
Published in Cephalalgia (01.10.2010)
Get full text
Journal Article
Loading…
Abuse Potential of Lasmiditan: A Phase 1 Randomized, Placebo‐ and Alprazolam‐Controlled Crossover Study
Wilbraham, Darren, Berg, Paul H., Tsai, Max, Liffick, Emily, Loo, Li Shen, Doty, Erin Gautier, Sellers, Edward
Published in Journal of clinical pharmacology (01.04.2020)
Published in Journal of clinical pharmacology (01.04.2020)
Get full text
Journal Article
Loading…
Effects of Lasmiditan on Cardiovascular Parameters and Pharmacokinetics in Healthy Subjects Receiving Oral Doses of Propranolol
Tsai, Max, Case, Michael, Ardayfio, Paul, Hochstetler, Helen, Wilbraham, Darren
Published in Clinical pharmacology in drug development (01.07.2020)
Published in Clinical pharmacology in drug development (01.07.2020)
Get full text
Journal Article
Loading…
Loading…
Short-term efficacy and safety of lasmiditan, a novel 5-HT1F receptor agonist, for the acute treatment of migraine: a systematic review and meta-analysis
Hou, Min, Xing, Haiyan, Li, Chen, Wang, Xianfeng, Deng, Dongmei, Li, Juan, Zhang, Pan, Chen, Jianhong
Published in Journal of headache and pain (05.06.2020)
Published in Journal of headache and pain (05.06.2020)
Get full text
Journal Article
Loading…
Loading…
Short-term efficacy and safety of lasmiditan, a novel 5-HT 1F receptor agonist, for the acute treatment of migraine: a systematic review and meta-analysis
Hou, Min, Xing, Haiyan, Li, Chen, Wang, Xianfeng, Deng, Dongmei, Li, Juan, Zhang, Pan, Chen, Jianhong
Published in Journal of headache and pain (05.06.2020)
Published in Journal of headache and pain (05.06.2020)
Get full text
Journal Article
Loading…
Acute treatment of migraine with the selective 5-HT 1F receptor agonist lasmiditan – A randomised proof-of-concept trial
Ferrari, Michel D, Färkkilä, Markus, Reuter, Uwe, Pilgrim, Alison, Davis, Charles, Krauss, Martin, Diener, Hans-Christoph
Published in Cephalalgia (01.10.2010)
Published in Cephalalgia (01.10.2010)
Get full text
Journal Article
Loading…
Loading…
Loading…
Ditans: a new prospective for the therapy of migraine attack?
Viticchi, Giovanna, Falsetti, Lorenzo, Silvestrini, Mauro, Bartolini, Marco
Published in Neurological sciences (01.09.2022)
Published in Neurological sciences (01.09.2022)
Get full text
Journal Article
Loading…
Loading…
Lilly Completes Acquisition of CoLucid Pharmaceuticals
Published in PR Newswire
(01.03.2017)
Get full text
Newsletter
Loading…
CoLucid Pharmaceuticals, Inc
Published in GlobalData Company Deals and Alliances Profiles
(01.01.2014)
Get full text
Report
Loading…
CoLucid Pharmaceuticals, Inc
Published in GlobalData Company Deals and Alliances Profiles
(01.10.2013)
Get full text
Report
Loading…
PIPELINE
Published in Monthly Prescribing Reference
(01.09.2017)
Get full text
Trade Publication Article